Moderna raises full-year COVID-19 vaccine sales forecast to $21 bn
The company in February forecast sales of $19 billion from its signed contracts, and option for $3 billion in additional purchases.
Moderna yesterday raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion.
The company in February forecast sales of $19 billion from its signed contracts, and option for $3 billion in additional purchases.
It forecast additional purchases of roughly $500 million.
Edits by EP News Bureau
- Advertisement -